tirzepatide vision problems #Mounjaro & eyesight…. 2025 reality. The “blindness” stories are mostly about NAION (an eye-stroke). A large study found a very small increase (0.04% vs 0.02%) in people on #semaglutide / #tirzepatide What Is Ozempic Blindness? Research

These weight loss methods continue to help millions of people worldwide lose weight

They also had no use of the medications of interest within the past year

Visible fat loss changes are typically seen over 812 weeks of consistent use

Elevated WHR may signal the need for physician-guided weight loss evaluation

Compared with other GLP-1RAs, Semaglutide demonstrates superior blood sugar control and weight loss, as well as a lower risk of cardiovascular mortality and more benefits for the kidneys (Sorli et al

Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in alzheimers disease